(Q36652022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

FTY720 (fingolimod) in renal transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Harm Peters

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Johannes Waiser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Manuela Schütz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Petra Glander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Lutz Liefeldt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hans-H Neumayer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Torsten Böhler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Clinical Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

20 Suppl 17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

17-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppressive drugs for kidney transplantation.

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720--the first compound of a new promising class of immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

The immune modulator FTY720 targets sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Novel mediators of FTY720 in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Lymphoid organ development and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: different effects on CD62L+ and CCR5+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Structural and functional characteristics of S1P receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Sphingosine-1-phosphate mediates migration of mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

What do we know about the mechanism of action of disease-modifying treatments in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00596.X

10.1111/J.1399-0012.2006.00596.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17100697%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference